期刊文献+

不同溯源的两台血凝仪测定纤维蛋白原方法学比较 被引量:4

Methodology comparison of fibrinogen level detection by two coagulation analyzer in different traceability
下载PDF
导出
摘要 目的比较SYSMEX CA6000与STA Compact 2台血凝仪测定纤维蛋白原的结果,了解其偏倚的可接受性。方法根据美国临床实验室标准化委员会(NCCLS)EP9-A2文件,用2台血凝仪同时测定40例患者的纤维蛋白原,检查离群点并进行直线相关分析,计算医学决定水平处的预期偏倚。结果2台仪器测定结果均无离群点。直线回归方程为YΛ=0.851 6X-0.048 7,r=0.992。3个医学决定水平处预期偏倚分别为0.093、0.197、0.791 g/L。结论纤维蛋白原的3个医学决定水平处预期偏倚95%置信区间下限均低于允许偏倚,SYSMEX CA6000测定结果与STA Compact测定结果相当,偏倚可接受。 Objective To compare the fibrinogen level detected by two coagulation analyzer, SYSMEX CA6000 and STA Compact, and comprehend the acceptability on bias. Methods According to the relevant document EP9-A2 of National Committee for Clinical Laboratory Standards (NCCLS) , fibrinogen level of 40 samples of patients were detected respectively by two different coagulation analyzers. Outliers' detection and the correlation between two sets of results were analyzed. The expected bias at medical decision levels were calculated. Results There was no outlier in two re- sults. The regression equation was Y = 0. 851 6X -0. 048 7, r = 0. 992. The expected bias of fibrinogen at three medical decision levels were 0.093,0. 197 and 0. 791 g/L respectively. Conclusions The upper limits of 95% confidence in- terval of expected bias at three medical decision levels were all lower than acceptable bias. So the results between SYS- MEX CA6000 and STA COMPACT were equal, the bias was accepted.
出处 《检验医学》 CAS 北大核心 2009年第4期278-280,共3页 Laboratory Medicine
关键词 纤维蛋白原 血凝仪 溯源性 Fibrinogen Coagulation analyzer Traceability
  • 相关文献

参考文献5

二级参考文献3

共引文献240

同被引文献32

  • 1彭黎明 ,王鸿利 .我国临床血液学检验亟待解决的问题[J].中华检验医学杂志,2005,28(3):235-236. 被引量:40
  • 2张茉莉,谢守军,薛承岩.影响活化部分凝血活酶时间测定的因素[J].河北医学,2006,12(11):1196-1197. 被引量:3
  • 3Linnet K.Evaluation of regression procedures for method comparison studies[J].Clin Chem,1993,39(6):424-432.
  • 4Zwilinger D,Kokoska S.CRC Standard probability and statistics tables and formulae[J].Boca Raton Florida:CRC Press,1999:270.
  • 5冯仁丰.临床检验质量管理基础[M].2版.上海:上海科学技术文献出版社,2007:413.
  • 6叶应妩;王毓三;申子瑜.全国临床检验操作规程[M],200780-81.
  • 7NCCLS. Method Comparison and Bias Estimation Using Patient Samples;Approved Guideline-Second Edition.NCCLS document EP9-A2[ISBN1-56238-472-4][M].NCCLS,940 West Valley Road,Suite 1400,Wayne,Pennsylvanis 19087-1898 USA,2002.
  • 8杨有业;张秀明;王前.临床检验方法学评价[M]{H}北京:人民卫生出版社,2008121-135.
  • 9Tripodi A,Arbini A,Chantarangkul V,Mannucci PM. Recombinant tissue factor as substitude for conventional thrombopiastn in the prothrombin time test[J].{H}Thrombosis and Haemostasis,1992,(01):42-45.
  • 10Rizza CR,Walker W. One-stage prothrombine time techniques[A].{H}New York:Academic Press,Inc,1971.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部